Sylvester Comprehensive Cancer Center

  • 20160793 - Barredo Julio

  • Investigator:
    Julio Barredo
    RCname Email

    		Coordinator:
    RCemailImg Eva Pavicic
    RCphone +1 (305) 2437846

    IRB: 20160793

    		SDG: Pediatric Cancer
    Disease Site(s):

    Soft Tissue
    Sponsor: Moffitt Cancer Center

    Enrolling Sites:

    JMH
    Sylvester
    Title:

    Phase II Study of nab-Paclitaxel in Combination with Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults
    Eligibility Criteria - NCT02945800 *This information has been extracted from " www.clinicaltrials.gov"

  • 19487 - Barredo, Julio

  • Investigator:
    Julio Barredo
    RCname Email

    		Coordinator:
    RCemailImg Eva Pavicic
    RCphone +1 (305) 2437846

    IRB: 20181082

    		SDG: Pediatric Cancer
    Disease Site(s):

    Bones and Joints
    Sponsor: Moffitt Cancer Center

    Enrolling Sites:

    JMH
    Sylvester
    Title:

    19487: A Phase Ib/II Study to Evaluate the Safety, Feasibility and Efficacy of Nivolumab or Nivolumab in Combination with Azacitidine in Patients with Recurrent, Resectable Osteosarcoma
    Eligibility Criteria - NCT03628209 *This information has been extracted from " www.clinicaltrials.gov"

  • TAPUR - Calfa, Carmen

  • Investigator:
    Carmen Calfa
    RCname Email

    		Coordinator:
    RCemailImg Carolina Troche
    RCphone +1 (305) 2431481

    IRB: 20170529

    		SDG: Breast Cancer
    Disease Site(s):

    Breast,Colon,Kaposis sarcoma,Kidney,Larynx,Liver,Lymphoid Leukemia,Multiple,Multiple Myeloma,Non-Hodgkin Lymphoma,Pancreas,Prostate,Soft Tissue
    Sponsor: ASCO

    Enrolling Sites:

    Aventura
    Deerfield
    Gables
    Kendall
    Plantation
    Sylvester
    Title:

    The Targeted Agent and Profiling Utilization Registry (TAPUR) Study
    Eligibility Criteria - NCT02693535 *This information has been extracted from " www.clinicaltrials.gov"

  • 20201132 - D'Amato Gina

  • Investigator:
    Gina D'Amato
    RCname Email

    		Coordinator:

    IRB: 20201132

    		SDG: Bone and Soft Tissue Cancers
    Disease Site(s):

    Soft Tissue
    Sponsor: Tracon

    Enrolling Sites:

    Sylvester
    Title:

    A Pivotal Trial Of Envafolimab, And Envafolimab In Combination With Ipilimumab, In Patients With Advanced Or Metastatic Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma Who Have Progressed On Prior Chemotherapy
    Eligibility Criteria - NCT04480502 *This information has been extracted from " www.clinicaltrials.gov"

  • 20201400 - D'Amato Gina

  • Investigator:
    Gina D'Amato
    RCname Email

    		Coordinator:

    IRB: 20201400

    		SDG: Bone and Soft Tissue Cancers
    Disease Site(s):

    Soft Tissue
    Sponsor: ETCTN

    Enrolling Sites:

    Sylvester
    Title:

    A Phase 2 Study of Talimogene Laherparepvec (T-VEC) and Radiation in Localized Soft Tissue Sarcoma
    Eligibility Criteria - NCT02923778 *This information has been extracted from " www.clinicaltrials.gov"

  • 20210889 - D'Amato Gina

  • Investigator:
    Gina D'Amato
    RCname Email

    		Coordinator:
    RCemailImg Ravipal Luthra

    IRB: 20210889

    		SDG: Population Sciences
    Disease Site(s):

    Bones and Joints
    Sponsor: SARC

    Enrolling Sites:

    Sylvester
    Title:

    SARC038: A Phase 2 Study of Regorafenib in Combination With Nivolumab in Patients With Refractory or Recurrent Osteosarcoma
    Eligibility Criteria - NCT04803877 *This information has been extracted from " www.clinicaltrials.gov"

  • 20210234 - Dhir Aditi

  • Investigator:
    Aditi Dhir
    RCname Email

    		Coordinator:
    RCemailImg Eva Pavicic
    RCphone +1 (305) 2437846

    IRB: 20210234

    		SDG: Pediatric Cancer
    Disease Site(s):

    Soft Tissue
    Sponsor: Moffitt Cancer Center

    Enrolling Sites:

    Sylvester
    Title:

    Evolutionary Inspired Therapy for Newly Diagnosed, Metastatic, Fusion Positive Rhabdomyosarcoma
    Eligibility Criteria - NCT04388839 *This information has been extracted from " www.clinicaltrials.gov"

  • MATCH - Huang, Marilyn

  • Investigator:
    Marilyn Huang
    RCname Email

    		Coordinator:
    RCemailImg Carolina Troche
    RCphone +1 (305) 2431481

    IRB: 20150671

    		SDG: Gynecologic Cancer
    Disease Site(s):

    Cervix Uteri,Colon,Corpus Uteri,Kaposis sarcoma,Kidney,Larynx,Liver,Multiple Myeloma,Non-Hodgkin Lymphoma,Other Female Genital,Ovary,Pancreas,Prostate,Soft Tissue
    Sponsor: ECOG

    Enrolling Sites:

    Coral Springs
    Deerfield
    Gables
    Hollywood
    Kendall
    Plantation
    Sylvester
    Title:

    Molecular Analysis for Therapy Choice (MATCH)
    Eligibility Criteria - NCT02465060 *This information has been extracted from " www.clinicaltrials.gov"

  • 20211131 - Jonczak Emily

  • Investigator:
    Emily Jonczak
    RCname Email

    		Coordinator:
    RCemailImg Sonali Kumar
    RCphone +1 (305) 2430279

    IRB: 20211131

    		SDG: Bone and Soft Tissue Cancers
    Disease Site(s):

    Bones and Joints
    Sponsor: ETCTN

    Enrolling Sites:

    Plantation
    Sylvester
    Title:

    Phase 2 Study of Rogaratinib (BAY 1163877) in the Treatment of Patients with Sarcoma Harboring Alterations in Fibroblast Growth Factor Receptor (FGFR) 1-4 and SDH-deficient Gastrointestinal Stromal Tumor (GIST)
    Eligibility Criteria - NCT04595747 *This information has been extracted from " www.clinicaltrials.gov"

  • 20190762 - Penedo Frank

  • Investigator:
    Frank Penedo
    RCname Email

    		Coordinator:

    IRB: 20190762

    		SDG: Population Sciences
    Disease Site(s):

    Anus,Bladder,Bones and Joints,Breast,Cervix Uteri,Colon,Corpus Uteri,Esophagus,Kaposis sarcoma,Kidney,Larynx,Lip, Oral Cavity and Pharynx,Liver,Lung,Melanoma, skin,Other Digestive Organ,Other Endocrine System,Other Female Genital,Other Male Genital,Other Respiratory and Intrathoracic Organs,Other Urinary,Ovary,Pancreas,Prostate,Rectum,Small Intestine,Soft Tissue,Stomach,Thyroid
    Sponsor: SCCC

    Enrolling Sites:

    Community Clinics
    Gables
    Sylvester
    UMH
    Title:

    Development of an eHealth-based Cognitive Behavioral Stress and Self-Management Intervention to Reduce Symptom Burden in HIV+ Gay and Bisexual MSM Treated for Non-Metastatic Cancer
    Eligibility Criteria - NCT04544917 *This information has been extracted from " www.clinicaltrials.gov"

  • AMC- 096 - Ramos, Juan Carlos

  • Investigator:
    Juan Carlos Ramos
    RCname Email

    		Coordinator:

    IRB: 20180804

    		SDG: Bone and Soft Tissue Cancers
    Disease Site(s):

    Kaposis sarcoma
    Sponsor: AMC

    Enrolling Sites:

    Sylvester
    Title:

    AMC-096: A Phase II Study of sEphB4-HSA in Kaposi Sarcoma
    Eligibility Criteria - NCT02799485 *This information has been extracted from " www.clinicaltrials.gov"

  • 20210970 - Trent Jonathan

  • Investigator:
    Jonathan Trent
    RCname Email

    		Coordinator:

    IRB: 20210970

    		SDG: Bone and Soft Tissue Cancers
    Disease Site(s):

    Bones and Joints
    Sponsor: Foghorn Therapeutics

    Enrolling Sites:

    Sylvester
    Title:

    A phase 1, multicenter, open-label, dose escalation and expansion study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical activity of intravenously administered fhd-609 in subjects with advanced synovial sarcoma
    Eligibility Criteria - NCT04965753 *This information has been extracted from " www.clinicaltrials.gov"